Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04669548 · ClinicalTrials.gov registry record
Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry
A clinical trial of Acute Kidney Injury and Intra-Abdominal Hypertension, sponsored by Potrero Medical.
- Recruiting
- Registry status
- 2,500
- Enrollment target
- 9
- Study locations
NCT04669548: Recruiting study of Acute Kidney Injury and Intra-Abdominal Hypertension, sponsored by Potrero Medical.
NCT04669548 is a study of Acute Kidney Injury and Intra-Abdominal Hypertension that is actively recruiting participants, run by Potrero Medical. The registered enrollment target is 2,500 participants, roughly in line with the 2,297-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target. The trial reports 9 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04669548, a study of Acute Kidney Injury and Intra-Abdominal Hypertension, is actively recruiting participants, sponsored by Potrero Medical.
- RECRUITING
- Registry status
- 2,500 participants
- Enrollment target
- 9
- Study locations
Study Summary
The Accuryn Registry Study is an open-ended, global, multi-center, retrospective and prospective, single-arm data collection study with an FDA cleared device. The target population are cardiovascular surgery patients. Physiologic data measurements will be collected from enrolled subjects using electronic medical records and data streams via the Accuryn Monitoring System.
Primary Outcome
High accuracy Urine Output (mL/hour) while on a urinary catheter, and estimated UO while not on a urinary catheter
Conditions Studied
Interventions
- DEVICE Accuryn Monitoring System
Study Locations (9)
North Carolina
- Mission Health Hospital - Asheville
- Duke University Hospital - Durham
- Wake Forest Baptist Medical Center - Winston-Salem
California
- Cedars-Sinai Medical Center - Los Angeles
- San Francisco VA Medical Center - San Francisco
District of Columbia
- George Washington University Hospital - Washington D.C.
Florida
- Cleveland Clinic Florida - Weston
Kentucky
- Jewish Hospital / University of Louisville - Louisville
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,500 participants |
| Start Date | 2020-12-21 |
| Est. Completion | 2026-12-31 |
What NCT04669548 shows while recruiting
NCT04669548 is an observational study that tracks outcomes without assigning an intervention. Its 2,500 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 2,297-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target.
The record links to 4 conditions, with Acute Kidney Injury appearing as the primary indexed condition, and to 1 intervention - of which Accuryn Monitoring System is the first listed.
NCT04669548 lists 9 locations in 6 states (North Carolina, California, District of Columbia).
Frequently Asked Questions
What is clinical trial NCT04669548 about?
NCT04669548 is a clinical study titled "Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry". The Accuryn Registry Study is an open-ended, global, multi-center, retrospective and prospective, single-arm data collection study with an FDA cleared device. The target population are cardiovascular surgery patients. Physiologic data measurements will be collected from enrolled subjects using elect...
What is the current status of trial NCT04669548?
This trial is currently recruiting. The enrollment target is 2,500 participants. The study started on 2020-12-21. Estimated completion is 2026-12-31.
What conditions does trial NCT04669548 study?
This clinical trial studies the following conditions: Acute Kidney Injury, Intra-Abdominal Hypertension, Abdominal Compartment Syndrome, Cardiovascular Surgery.
What interventions are being tested in trial NCT04669548?
The interventions under investigation include: Accuryn Monitoring System (DEVICE).
Who is sponsoring clinical trial NCT04669548?
This trial is sponsored by Potrero Medical, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04669548 being conducted?
This trial has 9 study locations across California, District of Columbia, Florida, Kentucky, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Kidney Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04669548's enrollment target sits among peer trials
2,500 7th of 74 higher than 68 of 74 other Acute Kidney Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Kidney Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ultra-Low Contrast Angiography in AKI
RECRUITING · Phase 3
-
Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy
RECRUITING
-
Droxidopa to Increase Mean Arterial Pressure in Decompensated Cirrhosis Patients With Acute Kidney Injury
RECRUITING · Phase 2
-
Theophylline Prophylaxis During Hypothermia to Limit Neonatal Nephron Damage
RECRUITING · Phase 1
-
Groundbreaking Renal Assist Device Intervening to ENhance cardioThoracic Surgery Outcomes
RECRUITING · NA
-
Melatonin for Prevention of Kidney Injury
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001160 · 2,500 participants
Studies on Tumors of the Thyroid
- NCT01904188 · 2,500 participants
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
- NCT02257229 · 2,500 participants
Prospective Evaluation of Treatment for Clubfoot
- NCT02530658 · 2,500 participants
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI